Evidence map›Paper›PMID 35521229›Full record

ReviewRSC advances2020

Application of blocking and immobilization of electrospun fiber in the biomedical field.

Yuanlan Ning, Wen Shen, Fen Ao

Open access · goldAbstract readReview
In one paragraph

Review in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Application of Electrospinning in Antibacterial Field.Nanomaterials (Basel, Switzerland) · 2021
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yuanlan NingSchool of Food and Biological Engineering, Shaanxi University of Science & Technology Xi'an 710021 PR China 863233866@qq.com shenwensm@sust.edu.cn +86-187-2925-6877 +86-187-1726-7199.ORCID https://orcid.org/0000-0002-3885-738X
Wen ShenSchool of Food and Biological Engineering, Shaanxi University of Science & Technology Xi'an 710021 PR China 863233866@qq.com shenwensm@sust.edu.cn +86-187-2925-6877 +86-187-1726-7199.
Fen AoSchool of Food and Biological Engineering, Shaanxi University of Science & Technology Xi'an 710021 PR China 863233866@qq.com shenwensm@sust.edu.cn +86-187-2925-6877 +86-187-1726-7199.
China XD Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fiber obtained by electrospinning technology is a kind of biomaterial with excellent properties, which not only has a unique micro-nanostructure that gives it a large specific surface area and porosity, but also has satisfactory biocompatibility and degradability (if the spinning material used is a degradable polymer). These biomaterials provide a suitable place for cell attachment and proliferation, and can also achieve immobilization. On the other hand, its large porosity and three-dimensional spatial structure show unique blocking properties in drug delivery applications in order to achieve the purpose of slow release or even controlled release. The immobilization effect or blocking effect of these materials is mainly reflected in the hollow or core-shell structure. The purpose of this paper is to understand the application of the electrospun fiber based on biodegradable polymers (aliphatic polyesters) in the biomedical field, especially the immobilization or blocking effect of the electrospun fiber membrane on cells, drugs or enzymes. This paper focuses on the performance of these materials in tissue engineering, wound dressing, drug delivery system, and enzyme immobilization technology. Finally, based on the existing research basis of the electrospun fiber in the biomedical field, a potential research direction in the future is put forward, and few suggestions are also given for the technical problems that urgently need to be solved.

Identifiers

PMID35521229
PMCPMC9057162
OpenAlexW3092529425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.